[EVAR] Lombard Medical, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 0.6 Change: -0.04 (-6.05%)
Ext. hours: Change: 0 (0%)

chart EVAR

Refresh chart

Description: Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, and internationally. The company?s principal product is Aorfix, which is an endovascular stent-graft for the treatment of an abdominal aortic aneurysm with angulation at the neck of the aneurysm of up to 90 degrees. It is also developing stent-graft system to treat thoracic aortic aneurysms. Lombard Medical sells its products directly through its direct sales force and third-party distributors. The company was founded in 2000 and is based in Didcot, United Kingdom.

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities49.66 M Cash From Investing Activities-1.75 M Cash From Operating Activities-34.21 M Gross Profit1.58 M
Net Profit-9.54 M Operating Profit-9.76 M Total Assets63.41 M Total Current Assets54.94 M
Total Current Liabilities6.18 M Total Debt2.65 M Total Liabilities8.83 M Total Revenue3.41 M
Technical Data
High 52 week0.81 Low 52 week0.22 Last close0.22 Last change0%
RSI12.8 Average true range0.11 Beta0.3 Volume137.54 K
Simple moving average 20 days-27.04% Simple moving average 50 days-43.27% Simple moving average 200 days-56.7%
Performance Data
Performance Week1.36% Performance Month-48.14% Performance Quart-49.32% Performance Half-48.14%
Performance Year-68.14% Performance Year-to-date-62.83% Volatility daily6.9% Volatility weekly15.43%
Volatility monthly31.63% Volatility yearly109.57% Relative Volume201.51% Average Volume77.46 K
New High New Low

News

2017-11-09 09:00:00 | OTC Markets Group Welcomes Lombard Medical to OTCQX

2017-10-31 09:30:00 | Lombard Medical Reports First Half and Third Quarter 2017 Financial Results

2017-10-30 16:00:00 | Lombard Medical Announces Shares to Trade on OTCQX

2017-10-04 15:06:10 | What You Must Know About Lombard Medical Inc’s EVAR Risks

2017-09-26 04:00:00 | Lombard Medical’s New Delivery System for Aorfix™ Endovascular Aortic Aneurysm Repair System Launched in Japan

2017-09-20 09:57:20 | One Thing To Consider Before Buying Lombard Medical Inc EVAR

2017-09-20 04:00:00 | Lombard Medical Appoints Jonathan Hornsby as Vice President, Sales & Marketing

2017-09-13 04:00:00 | Lombard Medical Announces Completion of Restructuring and Implementation of Strategic Plan to Achieve Profitability

2017-05-26 08:40:29 | Lombard Medical, Inc. :EVAR-US: Earnings Analysis: Q4, 2016 By the Numbers : May 26, 2017

2017-05-15 04:00:00 | Lombard Medical Announces First Patient Enrolled and Treated in the ALTITUDE Registry for the Altura® Stent Graft System

2017-05-04 04:00:00 | Lombard Medical’s Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium

2017-04-20 14:25:00 | Lombard Medical Appoints New CEO

2017-04-18 05:00:42 | Lombard Medical reports 4Q loss

2017-04-18 03:30:00 | Lombard Medical Reports 2016 Fourth Quarter, Full Year Financial Results

2017-04-18 03:00:00 | Lombard Medical’s CEO Steps Down

2017-04-03 06:00:00 | Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements

2017-02-07 06:00:00 | Lombard Medical Announces Successful Completion of First 15 Cases in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent Graft

2017-01-05 06:00:00 | Lombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

2016-12-23 18:05:31 | How MDT’s Endurant II/IIs Stent Graft System Will Boost Business

2016-12-23 10:00:00 | EVAR: $15M Investment, Additional Positive Outcomes Data

2016-12-19 11:01:54 | MPSC and Lombard Medical Announce Strategic Partnership and Inve...

2016-12-19 06:41:13 | Lombard Medical and MicroPort Scientific Corporation Announce Strategic Partnership and Investment Agreement

2016-12-19 06:00:00 | Lombard Medical and MicroPort Scientific Corporation Announce Strategic Partnership and Investment Agreement

2016-12-05 06:00:00 | Positive Long-Term Data for Lombard Medical’s Aorfix™ Endovascular Stent Graft System Confirms Sustained Performance in the Most Challenging Anatomies

2016-11-21 12:11:14 | Multi-Centre Early Experience and Data Presented on Lombard Medical’s Altura® Endovascular Stent Graft at the 43rd Annual VEITHsymposium™

2016-11-21 12:04:14 | Multi-Centre Early Experience and Data Presented on Lombard Medical’s Altura® Endovascular Stent Graft at the 43rd Annual VEITHsymposium™

2016-11-15 16:08:15 | Lombard Medical Receives NASDAQ Notice of Bid Price Deficiency

2016-11-15 16:00:00 | 4:00 pm Lombard Medical receives Nasdaq notice of bid price deficiency; no immediate effect on listing - has 180 days to regain compliance starting November 9, 2016

2016-11-15 16:00:00 | Lombard Medical Receives NASDAQ Notice of Bid Price Deficiency

2016-11-14 06:07:09 | Lombard Medical Announces Scientific Presentations on Aorfix™ and Altura® Endovascular Stent Grafts at the 43nd Annual VEITHsymposium™

2016-11-14 06:00:00 | Lombard Medical Announces Scientific Presentations on Aorfix™ and Altura® Endovascular Stent Grafts at the 43nd Annual VEITHsymposium™

2016-11-01 14:00:00 | EVAR: Benefits From IntelliFlex, Sales Reorg Not Yet Fully Realized

2016-10-31 12:36:34 | Lombard Medical, Inc. :EVAR-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016

2016-10-27 17:49:28 | Lombard Medical reports 3Q loss

2016-10-27 16:06:06 | Lombard Medical Reports 2016 Third Quarter, Nine-Month Financial Results

2016-10-27 16:00:00 | Lombard Medical Reports 2016 Third Quarter, Nine-Month Financial Results

2016-08-24 11:00:00 | EVAR: Exiting Underperforming U.S. Market and Seeking 'Strategic Alternatives'

2016-08-22 18:48:34 | Edited Transcript of EVAR earnings conference call or presentation 22-Aug-16 8:30pm GMT

2016-08-22 16:08:01 | Lombard Medical Reports 2016 Second Quarter, Six-Month Financial Results and Provides Update on Strategic Initiatives

2016-08-22 16:06:37 | Lombard Medical reports 2Q loss

2016-08-22 16:00:00 | Lombard Medical Reports 2016 Second Quarter, Six-Month Financial Results and Provides Update on Strategic Initiatives

2016-08-22 07:07:01 | Q2 2016 Lombard Medical Inc Earnings Release - After Market Close

2016-08-12 16:11:06 | Lombard Medical Reschedules 2016 Second Quarter, Six-Month Financial Results Release and Conference Call Date to August 22 to Provide Complete Information on Operational Initiatives

2016-08-12 16:00:00 | Lombard Medical Reschedules 2016 Second Quarter, Six-Month Financial Results Release and Conference Call Date to August 22 to Provide Complete Information on Operational Initiatives

2016-08-08 06:08:06 | Lombard Medical Announces 2016 Second Quarter, Six-Month Financial Results Release and Conference Call Date

2016-07-06 06:11:01 | Lombard Medical Expands European Launch of its New Altura® Endograft System

2016-06-30 06:11:01 | Lombard Medical Announces First Commercial Use of its New IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

2016-06-20 12:39:03 | Lombard Medical Announces CE Mark Approval for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

2016-06-16 08:39:14 | Lombard Medical to Initiate the Altura® ALTITUDE Global Registry to Evaluate the Treatment of Abdominal Aortic Aneurysms Across a Wide Range of “Real-World” Endovascular Aneurysm Repair Interventions

2016-06-13 06:09:06 | Lombard Medical Reports Positive Five-Year Aorfix™ Endovascular Stent Graft Clinical Results in AAA Patients with Challenging Anatomy